BRCA1: A Novel Prognostic Factor in Resected Non-Small-Cell Lung Cancer
Rafael Rosell, Marcin Skrzypski, Ewa Jassem et al. · 2007
Read BRCA1: A Novel Prognostic Factor in Resected Non-Small-Cell Lung Cancer by Rafael Rosell, Marcin Skrzypski, Ewa Jassem et al. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001129.txt.
Description
Early-stage lung cancer can be cured by surgery, yet patients at the same stage often fare very differently. Rafael Rosell and co-authors looked for a gene that helps explain that spread, in a 2007 PLOS ONE article. Their candidate was BRCA1, a gene better known from breast and ovarian cancer.
The study covers non-small-cell lung cancer that was removed by surgery. Gene expression profiles can sort patients into groups with different outlooks even within one stage. The authors present BRCA1 as a new prognostic factor, meaning its levels carry information about likely survival. Such markers could one day guide who needs extra treatment after surgery.
Catalog record
| CREATOR | Rafael Rosell, Marcin Skrzypski, Ewa Jassem et al. |
|---|---|
| YEAR | 2007 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001129